165 related articles for article (PubMed ID: 37683725)
21. Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer's Disease Brain.
Suttapitugsakul S; Stavenhagen K; Donskaya S; Bennett DA; Mealer RG; Seyfried NT; Cummings RD
Mol Cell Proteomics; 2022 Dec; 21(12):100433. PubMed ID: 36309312
[TBL] [Abstract][Full Text] [Related]
22. Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy.
Gbormittah FO; Lee LY; Taylor K; Hancock WS; Iliopoulos O
J Proteome Res; 2014 Nov; 13(11):4889-900. PubMed ID: 25184692
[TBL] [Abstract][Full Text] [Related]
23. Glycoproteomics in Cerebrospinal Fluid Reveals Brain-Specific Glycosylation Changes.
Baerenfaenger M; Post MA; Langerhorst P; Huijben K; Zijlstra F; Jacobs JFM; Verbeek MM; Wessels HJCT; Lefeber DJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768261
[TBL] [Abstract][Full Text] [Related]
24. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012.
Leymarie N; Griffin PJ; Jonscher K; Kolarich D; Orlando R; McComb M; Zaia J; Aguilan J; Alley WR; Altmann F; Ball LE; Basumallick L; Bazemore-Walker CR; Behnken H; Blank MA; Brown KJ; Bunz SC; Cairo CW; Cipollo JF; Daneshfar R; Desaire H; Drake RR; Go EP; Goldman R; Gruber C; Halim A; Hathout Y; Hensbergen PJ; Horn DM; Hurum D; Jabs W; Larson G; Ly M; Mann BF; Marx K; Mechref Y; Meyer B; Möginger U; Neusüβ C; Nilsson J; Novotny MV; Nyalwidhe JO; Packer NH; Pompach P; Reiz B; Resemann A; Rohrer JS; Ruthenbeck A; Sanda M; Schulz JM; Schweiger-Hufnagel U; Sihlbom C; Song E; Staples GO; Suckau D; Tang H; Thaysen-Andersen M; Viner RI; An Y; Valmu L; Wada Y; Watson M; Windwarder M; Whittal R; Wuhrer M; Zhu Y; Zou C
Mol Cell Proteomics; 2013 Oct; 12(10):2935-51. PubMed ID: 23764502
[TBL] [Abstract][Full Text] [Related]
25. Glycoproteomics: Charting new territory in mass spectrometry and glycobiology.
Malaker SA
J Mass Spectrom; 2024 Jun; 59(6):e5034. PubMed ID: 38726698
[TBL] [Abstract][Full Text] [Related]
26. Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.
Peixoto A; Ferreira D; Azevedo R; Freitas R; Fernandes E; Relvas-Santos M; Gaiteiro C; Soares J; Cotton S; Teixeira B; Paulo P; Lima L; Palmeira C; Martins G; Oliveira MJ; Silva AMN; Santos LL; Ferreira JA
J Exp Clin Cancer Res; 2021 Jun; 40(1):191. PubMed ID: 34108014
[TBL] [Abstract][Full Text] [Related]
27. Global and site-specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry.
Xiao H; Sun F; Suttapitugsakul S; Wu R
Mass Spectrom Rev; 2019 Aug; 38(4-5):356-379. PubMed ID: 30605224
[TBL] [Abstract][Full Text] [Related]
28. A Comprehensive, Open-source Platform for Mass Spectrometry-based Glycoproteomics Data Analysis.
Liu G; Cheng K; Lo CY; Li J; Qu J; Neelamegham S
Mol Cell Proteomics; 2017 Nov; 16(11):2032-2047. PubMed ID: 28887379
[TBL] [Abstract][Full Text] [Related]
29. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
Xiao H; Suttapitugsakul S; Sun F; Wu R
Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
[TBL] [Abstract][Full Text] [Related]
30. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
Chen Z; Yu Q; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Asthana S; Carlsson C; Okonkwo O; Li L
Mol Cell Proteomics; 2021; 20():100081. PubMed ID: 33862227
[TBL] [Abstract][Full Text] [Related]
31. Critical considerations in N-glycoproteomics.
Chau TH; Chernykh A; Kawahara R; Thaysen-Andersen M
Curr Opin Chem Biol; 2023 Apr; 73():102272. PubMed ID: 36758418
[TBL] [Abstract][Full Text] [Related]
32. Glycosylation Analysis for Congenital Disorders of Glycosylation.
Li X; Raihan MA; Reynoso FJ; He M
Curr Protoc Hum Genet; 2015 Jul; 86():17.18.1-17.18.22. PubMed ID: 26132001
[TBL] [Abstract][Full Text] [Related]
33. N-glycoproteomics reveals distinct glycosylation alterations in NGLY1-deficient patient-derived dermal fibroblasts.
Budhraja R; Saraswat M; De Graef D; Ranatunga W; Ramarajan MG; Mousa J; Kozicz T; Pandey A; Morava E
J Inherit Metab Dis; 2023 Jan; 46(1):76-91. PubMed ID: 36102038
[TBL] [Abstract][Full Text] [Related]
34. Databases and Bioinformatic Tools for Glycobiology and Glycoproteomics.
Li X; Xu Z; Hong X; Zhang Y; Zou X
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937895
[TBL] [Abstract][Full Text] [Related]
35. Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells.
Xue B; Xiao K; Wang Y; Tian Z
J Proteomics; 2020 Feb; 212():103594. PubMed ID: 31759178
[TBL] [Abstract][Full Text] [Related]
36. Chemical methods for glycoprotein discovery.
Bond MR; Kohler JJ
Curr Opin Chem Biol; 2007 Feb; 11(1):52-8. PubMed ID: 17174139
[TBL] [Abstract][Full Text] [Related]
37. A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1.
Bagdonaite I; Nordén R; Joshi HJ; Dabelsteen S; Nyström K; Vakhrushev SY; Olofsson S; Wandall HH
PLoS Pathog; 2015 Apr; 11(4):e1004784. PubMed ID: 25830354
[TBL] [Abstract][Full Text] [Related]
38. Site- and structure-specific characterization of the human urinary N-glycoproteome with site-determining and structure-diagnostic product ions.
Shen Y; Xiao K; Tian Z
Rapid Commun Mass Spectrom; 2021 Jan; 35(1):e8952. PubMed ID: 32965048
[TBL] [Abstract][Full Text] [Related]
39. Mapping the O-glycoproteome using site-specific extraction of O-linked glycopeptides (EXoO).
Yang W; Ao M; Hu Y; Li QK; Zhang H
Mol Syst Biol; 2018 Nov; 14(11):e8486. PubMed ID: 30459171
[TBL] [Abstract][Full Text] [Related]
40. Label-free glycopeptide quantification for biomarker discovery in human sera.
Mayampurath A; Song E; Mathur A; Yu CY; Hammoud Z; Mechref Y; Tang H
J Proteome Res; 2014 Nov; 13(11):4821-32. PubMed ID: 24946017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
